Cart
sales@molnova.com
Biotin-ε-aminocaproyl-Tyr(PO3H2)-Glu-Glu-Ile-OH
CAS No. 201422-05-1
Biotin-ε-aminocaproyl-Tyr(PO3H2)-Glu-Glu-Ile-OH( ——— )
Catalog No. M40090 CAS No. 201422-05-1
Biotin-ε-aminocaproyl-Tyr(PO3H2)-Glu-Glu-Ile-OH
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBiotin-ε-aminocaproyl-Tyr(PO3H2)-Glu-Glu-Ile-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionBiotin-ε-aminocaproyl-Tyr(PO3H2)-Glu-Glu-Ile-OH
-
DescriptionBiotin-ε-aminocaproyl-Tyr(PO3H2)-Glu-Glu-Ile-OH
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number201422-05-1
-
Formula Weight972.05
-
Molecular FormulaC41H62N7O16PS
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
G3-C12 TFA (848301-9...
G3-C12 TFA Salt is a specific galectin-3 binding peptide with Ksubdsub of 88 nM and shows anticancer activity.
-
Glembatumumab vedoti...
Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate with potent anticancer effects, utilized in the study of triple negative breast cancer (TNBC).
-
P110
Dynamin-related protein 1 (Drp1) inhibitor, inhibits Drp1 GTPase activity. Displays no effect on dynamin 1 or other mitochondrial dynamics-related proteins. Inhibits mitochondrial fission, dysfunction and reactive oxygen species (ROS) production in vitro. Reduces programmed cell death and improves cell viability by protecting mitochondrial integrity. Reduces mitochondrial fragmentation and mitochondrial ROS production in mouse model of Parkinson's disease. Cell permeable.
